Comparison Of Outcome Of Antibiotic Coated Vicryl Vs Non-Coated Vicryl In Abdominal Fascial Closure After Laparotomy In Children

Surgical Site Infection Clinical Trial

Official title:

Comparison Of Outcome Of Antibiotic Coated Vicryl Vs Non-Coated Vicryl In Abdominal Fascial Closure After Laparotomy In Children

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06129773
• Other study ID #: Adeel1
• Status: Completed
• Phase: N/A
• Start date: November 1, 2023
• Est. completion date: February 14, 2024

Study information

• Verified date: February 2024
• Source: Children Hospital and Institute of Child Health, Lahore
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

We are investigating outcome of antibiotic coated vicryl versus non coated vicryl in terms of rate of surgical site infection and lebgth of hospital stay in children after lalaprotomy for perforated viscera. total 100 patients will be taken and 50 in each group.

Description:

Pneumoperitoneum is typically a surgical emergency, particularly in children and more than 90% of occurrences are caused by perforation of the gastrointestinal tract and other hollow viscera. Wound infections after abdominal surgery are still frequent types of nosocomial infections. Sutures can be a source of wound infection and dehisence due to bacterial adherence and colonization. Sutures coated with antibacterial agents have been developed in an attempt to reduce bacterial adherence and colonization of suture materials. The objective of the study is to compare the outcome of antibiotic coated vicryl versus non-coated vicryl in abdominal fascial closure after laparotomy in children in regards of surgical site infections. It will be a randomized controlled trial in which 100 patients admitted in Children Hospital Lahore will be included. Simple random sampling will be carried out. Informed written consent will be taken from patients' guardian. The patients will be divided into two groups (50 in each group). Group-A patients will undergo laparotomy closure with antibiotic coated vicryl while Group-B patient will experience non-coated vicryl in abdominal fascial closure. All patients will be examined on 3rd, 7th and 30th post-operative day for wound infection according to Southampton wound scoring system. Data will be collected through predesigned proforma, which will be entered and statistically analyzed using SPSS version 24.0. For quantitative variables mean and standard deviation will be calculated and for qualitative variables frequency and percentages will be calculated. Data will be presented in tables and graphs. Chi-square test will be used to estimate the association between qualitative variables. P-value <0.05 will be considered significant. It is expected that results of this study may be helpful for healthcare providers to provide appropriate treatment to the patients and to prevent them from wound related complications.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: February 14, 2024
• Est. primary completion date: January 13, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 4 Hours to 15 Years

Eligibility

Inclusion Criteria:

• • Children with pneumoperitoneum / perforated viscus

• Children aged 0 day to 15 years

• Both genders

Exclusion Criteria:

• • Malnourished children

• Children aged above 15 years

• Clean surgeries

• Low Hb level

• Parents unwilling to take part

Related Conditions & MeSH terms

• Surgical Site Infection
• Surgical Wound Infection

Intervention

Procedure:
• antibiotic coated vicryl used for fascial closure
in this group fascial closure was done with antibiotic coated vicryl to compare with non coated vicryl after lapaprotomy in contaminated wounds

Locations

Country	Name	City	State
Pakistan	The Children Hospital	Lahore	Punjab

Sponsors (1)

Lead Sponsor	Collaborator
Muhammad Adeel Ashiq

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of surgical site infection	rate of surgical site infection will be measured in percentage	30 days